Dick Sundh | Vice President, Marketing & Head of Australia, Canada and Europe (ACE),
Kite Pharma, a Gilead Company
Dick Sundh is Vice President, Marketing and Head of Australia, Canada and Europe (ACE) at Kite, a Gilead Company. In his role, Mr Sundh oversees European commercial operations for Kite's growing portfolio of cell therapies.
Mr Sundh has more than 17 years' experience in international business management, with a focus on building strong teams and infrastructures that place patients at their centre. He started his sales and marketing career after obtaining a Bachelor of Science and Economics degree from Örebro University. Mr Sundh has since worked for some of Europe's leading pharmaceutical companies in numerous senior-level executive roles, including Vice President Marketing and Sales, Russia at AstraZeneca; Vice President Europe, Middle East, Africa and Canada (EMEAC) at St. Jude Medical and Vice President Europe, Middle East and Australia (EMEA) Region West at Gilead Sciences.
Appearances:
Day 1: Wednesday 19th May 2021 - Cell Therapy @ 11:30
Keynote panel discussion: State of the industry panel
- How have events over the last 12 months affected the industry? Maintaining
- Where is the ATMP field headed?
- Who is making the best progress?
- What is new on the market?
- The Next Wave: moving beyond CAR-T and Gene Therapy, what’s next?
Organiser
